Guidelines on acute infectious diarrhea in adults

American Journal of Gastroenterology

Volumn 92, Issue 11, 1997, Pages 1962-1975

  DuPont, Herbert L ^a,b  

^a American College of Gastroenterology   (United States)

^b MC 1 164 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIVIRUS AGENT; ATOVAQUONE; ATROPINE PLUS DIPHENOXYLATE; ATTAPULGITE; AZITHROMYCIN; BISMUTH SALICYLATE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; COTRIMOXAZOLE; DIASORB; ERYTHROMYCIN STEARATE; ETHAMBUTOL; FOSCARNET; GANCICLOVIR; KAOLIN PECTIN; LOPERAMIDE; METRONIDAZOLE; NORFLOXACIN; OCTREOTIDE; OFLOXACIN; PAROMOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; UNCLASSIFIED DRUG;

ACUTE DIARRHEA; ADULT; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CYTOMEGALOVIRUS INFECTION; GASTROENTERITIS; GASTROINTESTINAL INFECTION; GIARDIASIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE DEFICIENCY; MYCOBACTERIOSIS; ORAL DRUG ADMINISTRATION; PARASITISM; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; SHIGELLOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TRAVELLER DIARRHEA;

ACUTE DISEASE; ADULT; COMMUNICABLE DISEASES; DIARRHEA; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; TRAVEL;

EID: 0030708771     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Garthwright W, Archer D, Kvenberg J. Estimates of incidence and cost of intestinal infectious diseases in the United States. Public Health Rep 1988;103:107-15.
2. Feldman R, Banatvala N. The frequency of culturing stools from adults with diarrhoea in Great Britain. Epidemiol Infect 1994;113: 41-4.
3. Gangarosa R, Glass R, Lew J, et al. Hospitalizations involving gastroenteritis in the United States 1985: The special burden of the disease among the elderly. Am J Epidemiol 1992;135:281-90.
4. Lew J, Glass R, Gangarosa R, et al. Diarrheal deaths in the United States 1979 through 1987: A special problem for the elderly. JAMA 1991;265:3280-4.
5. Glass R, Lew J, Gangarosa R, et al. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991;118:527-33.
6. Faruque A, Mahalanabis D, Islam A, et al. Common diarrhea pathogens and the risk of dehydration in young children with acute watery diarrhea: A case-control study. Am J Trop Med Hyg 1993;49:93-100.
7. Oldfield E, Bourgeois A, Omar A-K, et al. Empirical treatment of Shigella dysentery with trimethoprim: Five-day course vs. single dose. Am J Trop Med Hyg 1987;37:616-23.
8. DuPont H. Review article. Infectious diarrhoea. Aliment Pharmacol Ther 1994;8:3-13.
9. Ericsson C, Patterson T, DuPont H. Clinical presentation as a guide to therapy for travelers' diarrhea. Am J Med Sci 1987;294:91-6.
10. Parish K, Chapman W, Williams L. Ischemic colitis: An ever-changing spectrum. Am Surg 1991;57:118.
11. Thuluvath P, McKendrick M. Salmonella and complications related to age - Sheffield experience. Q J Med 1988;67:497-503.
12. DuPont H, Marshall G. HIV-associated diarrhoea and wasting. Lancet 1995;346:352-6.
13. Quinn T, Stamm W, Goodell S, et al. The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med 1983;309: 576-82.
14. DuPont H. How safe is the food we eat? JAMA 1992;268:3240.
15. Hedberg C, MacDonald K, Osterholm M. Changing epidemiology of food-borne disease: A Minnesota perspective. Clin Infect Dis 1994; 18:671-82.
16. Mac Kenzie W, Hoxie N, Proctor M, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994;331:161-7.
17. Harris J, DuPont H, Hornick R. Fecal leukocytes in diarrheal illness. Ann Intern Med 1972;76:696-703.
18. McNeely W, DuPont H, Mathewson J, et al. Occult blood versus fecal leukocytes in the diagnosis of bacterial diarrhea. A study of U. S. travelers to Mexico and Mexican children. Am J Trop Med Hyg 1996; 55:430-3.
19. Oberhelman R, de la Cabada F, Garibay E, et al. Efficacy of trimethoprim-sulfamethoxazole treatment of acute diarrhea in a Mexican pediatric population. J Pediatr 1987;110:960-5.
20. DuPont H, Corrado M, Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 1987;82(suppl 6B):79-83.
21. DuPont H, Ericsson C, Mathewson J, et al. Five versus three days of ofloxacin therapy for traveler's diarrhea: A placebo-controlled study. Antimicrob Agents Chemother 1992;36:87-91.
22. Voegtliin J, Stalder H, Hurzeler L, et al. Modified guaiac test may replace search for faecal leucocytes in acute infectious diarrhoea. Lancet 1983;2:1204.
23. DuPont H. Nonfluid therapy and selected chemoprophylaxis of acute diarrhea. Am J Med 1985;78(suppl 6B):81-90.
24. DuPont H, Ericsson C, Robinson A, et al. Current problems in antimicrobial therapy for bacterial enteric infection. Am J Med 1987; 82(suppl 4A):324-8.
25. DuPont H, Reves R, Galindo E, et al. Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med 1982;307:841-4.
26. Ericsson C, Johnson P, DuPont H, et al. Ciprofloxacin and trimethoprim/sulfamethoxazole as initial therapy for acute travelers' diarrhea: A placebo-controlled randomized trial. Ann Intern Med 1987;106:216-20.
27. DuPont H, Ericsson C. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993;328:1821-7.
28. Jokipii L, Pohjola S, Jokipii A. Cryptosporidium: A frequent finding in patients with gastrointestinal symptoms. Lancet 1983;2:258-61.
29. Jokipii A, Jokipii L. Prepatency of giardiasis. Lancet 1977;1:1095-7.
30. Jokipii L, Jokipii A. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med 1986;315:1643-7.
31. Cohen R, Kalser M, Arteaga I, et al. Microbial intestinal flora in acute diarrheal disease. JAMA 1967;201:835-40.
32. Manabe Y, Vinetz J, Moore R, et al. Clostridium difficile colitis: An efficient clinical approach to diagnosis. Ann Intern Med 1965;123: 835-40.
33. Bhan M, Rai P, Levine M, et al. Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis 1989;159:1061-4.
34. George W, Nakata M, Thompson J, et al. Aeromonas-related diarrhea in adults. Arch Intern Med 1985;145:2207-11.
35. Koplan J, Fineberg H, Ferraro M, et al. Value of stool cultures. Lancet 1980;2:413-6.
36. Guerrant R, Shields D, Thorson S, et al. Evaluation and diagnosis of acute infectious diarrhea. Am J Med 1985;78:91-8.
37. Siegel D, Edelstein P, Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990;263:979-82.
38. Reed S. Amebiasis: An update. Clin Infect Dis 1992;14:385-93.
39. Jokipii L, Pohjola S, Jokipii A. Cryptosporidiosis associated with traveling and giardiasis. Gastroenterology 1985;89:838-42.
40. Connor B, Shlim D, Scholes J, et al. Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia-like body. Ann Intern Med 1993;119:377-82.
41. Wright R, Spencer H, Brodsky R, et al. Giardiasis in Colorado: An epidemiologic study. Am J Epidemiol 1977;105:330-6.
42. Pickering L, Woodward W, DuPont H, et al. Occurrence of Giardia lamblia in children in day care centers. J Pediatr 1984;104:522-6.
43. Tangermann R, Gordon S, Wiesner P, et al. An outbreak of cryptosporidiosis in a day-care center in Georgia. Am J Epidemiol 1991; 133:471-6.
44. Rendtorff R. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg 1954;59:209-220.
45. DuPont H, Chappell C, Sterling C, et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995;332: 855-9.
46. Kotler D, Francisco A, Clayton F, et al. Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med 1990;113:444-9.
47. Lopez C, Dykes A, Juranek D, et al. Waterborne giardiasis: A community-wide outbreak of disease and a high rate of asymptomatic infection. Am J Epidemiol 1980;112:495-507.
48. Ravdin R. Amebiasis. Clin Infect Dis 1995;20:1453-66.
49. Garcia L, Shum A, Bruckner D. Evaluation of new monoclonal antibody combination reagent for direct fluorescence detection of Giardia. Cysts and Cryptosporidium oocytes in human fecal specimens. J Clin Microbiol 1992;30:3255-7.
50. Dagan R, Fraser D, El-On J, et al. Evaluation of an enzyme-immunoassay for the detection of Cryptosporidium spp in stool specimens from infants and young children in field studies. Am J Trop Med Hyg 1995;52:134-8.
51. Rosoff J, Sanders C, Sonnad S, et al. Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65). J Clin Microbiol 1989;27:1997-2002.
52. Alles A, Waldron M, Sierra L, et al. Prospective comparison of direct immunofluorescence and conventional staining methods for detection of Giardia and Cryptosporidium spp in human fecal specimens. J Clin Microbiol 1995;33:1632-4.
53. Su C, Brandt L. Escherichia coli 0157:H7 infection in humans. Ann Intern Med 1995;123:698-714.
54. Morris J Jr, Black R. Cholera and other vibrioses in the United States. N Engl J Med 1985;312:343-50.
55. Lee L, Taylor J, Carter G, et al. Yersinia enterocolitica 0:3: An emerging cause of pediatric gastroenteritis in the United States. J Infect Dis 1991;163:660-3.
56. The management of acute diarrhea in children, oral rehydration, maintenance, and nutritional therapy. MMWR 1992;41 (October 16): 1-20.
57. Schiller L, Sannta Ana C, Morawski S, et al. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984;86:1475-80.
58. Johnson P, Ericsson C, DuPont H, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA 1986;225:757-60.
59. DuPont H, Sanchez J, Ericsson C, et al. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med 1990;88(suppl 6A):15S-19S.
60. DuPont H, Hornick R. Adverse effect of Lomotil therapy in shigellosis. JAMA 1973;226:1525-8.
61. Murphy G, Bodhidatta L, Echeverria P, et al. Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Ann Intern Med 1993;118:582-6.
62. Cimolai N, Carter J, Morrison B, et al. Risk factors for the progression of Escherichia coli 0157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr 1990;116:582-92.
63. Cimolai N, Morrison B, Carter J. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 1992;90:616-21.
64. DuPont H, Sullivan P, Pickering L, et al. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977;73:715-8.
65. Ericsson C, Evans D, DuPont H, et al. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis 1977;136:693-6.
66. Powell D, Tapper E, Morris S. Aspirin-stimulated intestinal electrolyte transport in rabbit ileum in vitro. Gastroenterology 1979;76: 1429-37.
67. DuPont H, Ericsson C, Johnson P, et al. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347-50.
68. Graham D, Estes M, Gentry L. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli. Gastroenterology 1983;85:1017-22.
69. Steinhoff M, Douglas R Jr, Greenberg H, et al. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 1980;78:1495-9.
70. DuPont H, Ericsson C, DuPont M, et al. A randomized open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am J Med 1990;88(suppl 6A):20S-23S.
71. Johanson J, Sonnenberg A. Efficient management of diarrhea in the acquired immunodeficiency syndrome (AIDS): A medical decision analysis. Ann Intern Med 1990;112:942-8.
72. Mendelowitz P, Hoffman R, Weber S. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy. Ann Intern Med 1990;112:140-1.
73. Simon D, Weiss L, Tanowitz H, et al. Light microscopic diagnosis of human microsporidiosis and variable response to octreotide. Gastroenterology 1991;100:271-3.
74. Haltalin K, Nelson J, Hinton L, et al. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis: A double blind study with ampicillin and neomycin. J Pediatr 1968;72:708-20.
75. DuPont H, Levine M, Hornick R, et al. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989;159:1126-8.
76. Nelson J, Kusmiesz H, Jackson L, et al. Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA 1976;235:1239-43.
77. Tauxe R, Puhr N, Wells J, et al. Antimicrobial resistance of Shigella isolates in the USA: The importance of international travelers. J Infect Dis 1990;162:1107-11.
78. Chalker R, Blaser M. A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis 1988;10:111-24.
79. Neill M, Opal S, Heelan J, et al. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute Salmonellosis: Experience during an outbreak in healthcare workers. Ann Intern Med 1991;114: 195-9.
80. Cherubin C, Neu H, Imperato P, et al. Septicemia with nontyphoid Salmonella Medicine 1974;53:365-76.
81. Nelson S, Granoff D. Salmonella gastroenteritis in the first three months of life. Clin Pediatr 1982;21:709-12.
82. Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year old residents of New York City. Clin Infect Dis 1994;18:358-63.
83. Lockyer W, Feinfeld D, Cherubin C, et al. An outbreak of Salmonella enteritis and septicemla in a populaton of uremic patients. Arch Intern Med 1980;140:943-5.
84. Han T, Sokal J, Neter E. Salmonellosis in disseminated malignant diseases. N Engl J Med 1967;276:1045-52.
85. Samra Y, Shaked Y, Maier M. Nontyphoid salmonellosis in renal transplant recipients. Rev Infect Dis 1988;8:431-40.
86. Mandal B, Brennand J. Bactaeremia in salmonellosis: A 15 year retrospective study from a regional infectious diseases unit. Br Med J 1988;297:1242-3.
87. Kuschner R, Trofa A, Thomas R, et al. Use of azithromycin for the treatment of campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995;21: 536-41.
88. Pai C, Gillis FE, Marks M. Erythromycin in treatment of campylobacter enteritis in children. Am J Dis Child 1983;137:286-8.
89. Petruccelli B, Murphy G, Sanchez J, et al. Treatment of travelers' diarrhea with ciprofloxacin and loperamide. J Infect Dis 1992;165: 557-60.
90. Rautelin H, Renkonen O, Kosunen T. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother 1991;35:2065-9.
91. Segreti J, Gootz T, Goodman L, et al. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis 1992;165: 667-70.
92. Mathewson J, Johnson P, DuPont H, et al. A newly recognized cause of travelers' diarrhea: Enteroadherent Escherichia coli. J Infect Dis 1985;151:471-5.
93. Cravioto A, Tello A, Navarro A, et al. Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet 1991;337:262-4.
94. Mathewson J, Jiang Z, Zumla A, et al. HEp-2 cell adherent Escherichia coil in patients with human immunodeficiency virus-associated diarrhea. J Infect Dis 1995;171:1636-9.
95. Yamamoto T, Echeverria P, Yokota T. Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli. J Infect Dis 1992;165:744-9.
96. DuPont H, Ericsson C, Mathewson J et al. Oral aztreonam a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 1992;267:1932-5.
97. Walterspiel J, Ashkenazi S, Morrow A, et al. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1. Infection 1992;20:25-9.
98. Pavia A, Nichols C, Green D, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli 0157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations. J Pediatr 1990;116:544-51.
99. Ostroff S, Kobayashi J, Lewis J. Infections with Escherichia coli 0157:H7 in Washington State: The first year of statewide disease surveillance. JAMA 1989;262:355-9.
100. Prouix F, Turgeon J, Delage G, et al. Randomized controlled trial of antibiotic therapy for Escherichia coli 0157:H7 enteritis. J Pediatr 1992;121:299-303.
101. Kozicki M, Steffen R, Schär J. "Boil it cook it peel it or forget it;" does this rule prevent travelers' diarrhoea? Int J Epidemiol 1985;14: 169-72.
102. Bandres J, Mathewson J, Ericsson C, et al. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella spp in Guadalajara, Mexico. Am J Med Sci 1992;303:289-91.
103. Murray B. Resistance of Shigella, Salmonella and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis 1986; 8(suppl 2):S172-81.
104. Ericsson C, DuPont H. Travelers' diarrhea: Approaches to prevention and therapy. Clin Infect Dis 1993;16:616-26.